← Leaderboards
Joanna Stanicka
Axonis Therapeutics, Inc.
$2,531,313
Attributed
$2,531,313
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2020–23$2M$1.5M$1M$500K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,531,313 · 2
By mechanism
R44$2,200,694 · 1
R43$330,619 · 1
Top collaborators
No co-investigators on record.
Most similar at Axonis Therapeutics, Inc.
Same institution · by research overlap
- Shane Hegarty$1,095,744
Others in their field
Other Emerging Leaders on “Injury”
- Ashlee Fitch · Steelworker Charitable/Educational Org$14,396,687
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Bryan L McLaughlin · Micro-Leads, Inc.$11,933,203
- Sharon Dziuba Yeatts · University Of Michigan At Ann Arbor$11,654,686
- Vera Hoffman · Reveal Pharma$10,532,099
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
InjuryMotor DeficitDoseHourIn VivoLesionChloridesCostEnhancersFeedingAdultIn VitroAnalogLeadActivities Of Daily LivingBiological AvailabilityAnatomyComorbidityAnimalsElectric StimulationChronicEvaluationCervical Spinal Cord InjuryMotor Function Recovery
Grant awards (3)
Development of KCC2 Neuromodulators to Treat Paralysis After Spinal Cord Injury.$1,426,925
R44 · FY2023 · NS · contact PI
Development of KCC2 neuromodulators to treat paralysis after spinal cord injury.$773,769
R44 · FY2022 · NS · contact PI
Development of KCC2 neuromodulators to treat paralysis after spinal cord injury.$330,619
R43 · FY2020 · NS · contact PI